MX2012013469A - Levocarrimicina, composiciones farmaceuticas, metodos de preparacion y usos de la misma. - Google Patents
Levocarrimicina, composiciones farmaceuticas, metodos de preparacion y usos de la misma.Info
- Publication number
- MX2012013469A MX2012013469A MX2012013469A MX2012013469A MX2012013469A MX 2012013469 A MX2012013469 A MX 2012013469A MX 2012013469 A MX2012013469 A MX 2012013469A MX 2012013469 A MX2012013469 A MX 2012013469A MX 2012013469 A MX2012013469 A MX 2012013469A
- Authority
- MX
- Mexico
- Prior art keywords
- levocarrimycin
- iii
- pharmaceutical compositions
- content
- isovalerylspiramycin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente invención se refiere a la levocarrimicina, sus composiciones farmacéuticas, métodos de preparación y aplicación. La levocarrimicina es una mezcla de isovalerilespiramicina III, II y I como componentes principales y contine alguna alguna isobutirilespiramicina III y II butirilespiramicina III y II propinolisespiramicina III y II así como acetilespiramicina III y II entre los que el contenido de isovalerilespiramicina III, II y I no es menor que 60% en peso, y el contenido de acilespiramicina es 80-98% en peso. La rotación óptica especifica de dicha levocarrimicina es [a[d =-52° - 57° en la solución de 0.02g/ml de cloroformo a la temperatura de 25°C. La presente invención se refiere además al compuesto cristalino de la isovalerilespiramicin a III, II o I en levocarrimicina y composiciones farmacéuticas que contienen dicha levocarrimicina . En la presente invención, los componentes activos de levocarricina o sus composiciones farmacéuticas presentan actividad óptica y excelente efecto anti-infeccioso.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010182027 | 2010-05-25 | ||
| PCT/CN2011/074658 WO2011147316A1 (zh) | 2010-05-25 | 2011-05-25 | 左旋可利霉素、其药物组合物、制备方法及应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2012013469A true MX2012013469A (es) | 2013-04-03 |
| MX346873B MX346873B (es) | 2017-03-30 |
Family
ID=44975203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012013469A MX346873B (es) | 2010-05-25 | 2011-05-25 | Levocarrimicina, composiciones farmacéuticas, métodos de preparación y usos de la misma. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9089586B2 (es) |
| EP (1) | EP2578596B1 (es) |
| JP (1) | JP5866737B2 (es) |
| KR (2) | KR101706519B1 (es) |
| CN (1) | CN102247396B (es) |
| BR (1) | BR112012029905B1 (es) |
| CA (1) | CA2800019C (es) |
| DK (1) | DK2578596T3 (es) |
| ES (1) | ES2633737T3 (es) |
| IN (1) | IN2012MN02623A (es) |
| MX (1) | MX346873B (es) |
| MY (1) | MY164230A (es) |
| PL (1) | PL2578596T3 (es) |
| RU (1) | RU2593499C2 (es) |
| WO (1) | WO2011147316A1 (es) |
| ZA (1) | ZA201209739B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2593498C2 (ru) * | 2010-05-25 | 2016-08-10 | Шенянг Тонглиан Груп Ко., Лтд | Левовращающие изовалерил-спирамицины 1, ii, iii, их препараты, способ приготовления и употребление |
| BR112013002675B1 (pt) * | 2010-08-04 | 2020-11-24 | Ima Life North America Inc. | sistemas e método de liofilização para liofilizar produto a granel |
| US9945611B2 (en) | 2010-08-04 | 2018-04-17 | Ima Life North America Inc. | Bulk freeze drying using spray freezing and agitated drying |
| CN103694295B (zh) * | 2014-01-08 | 2016-01-20 | 华东理工大学 | 一种优化可利霉素组分的方法 |
| CN105497053B (zh) * | 2015-12-31 | 2018-02-13 | 沈阳福洋医药科技有限公司 | 可利霉素在抗结核分枝杆菌感染中的应用 |
| AU2018247555B2 (en) | 2017-04-06 | 2024-04-18 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Use of carrimycin and pharmaceutically acceptable salt thereof for manufacture of medicament for treatment and/or prevention of tumors |
| MX2019015676A (es) * | 2017-07-04 | 2022-03-17 | Shenyang Fuyang Pharmaceutical Tech Co Ltd | Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento. |
| MX2020007625A (es) * | 2018-01-19 | 2020-11-24 | Shenyang Fuyang Pharmaceutical Tech Co Ltd | Inhibidor mtor, composicion farmaceutica y su uso. |
| WO2019141256A1 (zh) | 2018-01-19 | 2019-07-25 | 沈阳福洋医药科技有限公司 | 可利霉素或其活性成分的用途 |
| CN110384710B (zh) * | 2018-04-17 | 2023-01-10 | 沈阳福洋医药科技有限公司 | 一种用于预防和/或治疗疼痛的药物、组合产品及其应用 |
| JP2021533144A (ja) * | 2018-04-17 | 2021-12-02 | 上海同聯製薬有限公司Shanghai Tonglian Pharmaceutical Co., Ltd. | 疼痛及び／又は発熱を予防及び／又は治療するための薬物、組成製品及びその応用 |
| CN110384802B (zh) * | 2018-04-17 | 2021-09-17 | 沈阳福洋医药科技有限公司 | 一种用于预防和/或治疗发热的药物、组合产品及其应用 |
| CN108992416A (zh) * | 2018-09-27 | 2018-12-14 | 上海同联制药有限公司 | 一种可利霉素肠溶片及其制备方法 |
| US20220211735A1 (en) * | 2019-05-16 | 2022-07-07 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Medicament and combination product used for preventing, alleviating and/or treating fibrosis, and use thereof |
| CN112239483B (zh) * | 2019-07-18 | 2023-10-27 | 沈阳福洋医药科技有限公司 | 一种化合物及药物组合物 |
| CN111450066B (zh) * | 2020-04-24 | 2022-06-21 | 沈阳信达泰康医药科技有限公司 | 一种可利霉素冻干粉针制剂及其制备方法 |
| WO2021219112A1 (zh) * | 2020-04-30 | 2021-11-04 | 沈阳福洋医药科技有限公司 | 异戊酰螺旋霉素类化合物或其组合物在制备治疗脓毒症疾病药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5334788A (en) * | 1976-09-11 | 1978-03-31 | Sanraku Inc | Antibiotics spiramycin derivatives |
| CN1169947C (zh) | 2002-11-19 | 2004-10-06 | 中国医学科学院医药生物技术研究所 | 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195 |
| CN1237976C (zh) * | 2003-12-23 | 2006-01-25 | 沈阳同联集团有限公司 | 必特螺旋霉素及其在抗感染性疾病中的应用 |
| AU2005273592A1 (en) * | 2004-08-12 | 2006-02-23 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| KR100662363B1 (ko) * | 2004-10-19 | 2007-01-02 | 엘지전자 주식회사 | 디스플레이 기기의 인스톨 장치 및 방법 |
| CN101054553A (zh) * | 2007-04-09 | 2007-10-17 | 中国医学科学院医药生物技术研究所 | 异戊酰螺旋霉素i基因工程菌株的构建 |
| CN100554355C (zh) | 2007-04-11 | 2009-10-28 | 华南理工大学 | 一种纳米复合水性隔热外墙涂料及其制备方法 |
| CN101649325B (zh) * | 2009-07-03 | 2011-09-07 | 中国医学科学院医药生物技术研究所 | 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术 |
| RU2593498C2 (ru) * | 2010-05-25 | 2016-08-10 | Шенянг Тонглиан Груп Ко., Лтд | Левовращающие изовалерил-спирамицины 1, ii, iii, их препараты, способ приготовления и употребление |
-
2011
- 2011-05-25 ES ES11786088.2T patent/ES2633737T3/es active Active
- 2011-05-25 RU RU2012156419/04A patent/RU2593499C2/ru active IP Right Revival
- 2011-05-25 CN CN201110136228.XA patent/CN102247396B/zh active Active
- 2011-05-25 PL PL11786088T patent/PL2578596T3/pl unknown
- 2011-05-25 IN IN2623MUN2012 patent/IN2012MN02623A/en unknown
- 2011-05-25 JP JP2013511525A patent/JP5866737B2/ja active Active
- 2011-05-25 MY MYPI2012700968A patent/MY164230A/en unknown
- 2011-05-25 BR BR112012029905-0A patent/BR112012029905B1/pt not_active IP Right Cessation
- 2011-05-25 EP EP11786088.2A patent/EP2578596B1/en active Active
- 2011-05-25 CA CA2800019A patent/CA2800019C/en active Active
- 2011-05-25 DK DK11786088.2T patent/DK2578596T3/en active
- 2011-05-25 WO PCT/CN2011/074658 patent/WO2011147316A1/zh active Application Filing
- 2011-05-25 MX MX2012013469A patent/MX346873B/es active IP Right Grant
- 2011-05-25 KR KR1020167002375A patent/KR101706519B1/ko active IP Right Grant
- 2011-05-25 US US13/699,358 patent/US9089586B2/en active Active
- 2011-05-25 KR KR1020127033722A patent/KR101625262B1/ko active IP Right Grant
-
2012
- 2012-12-21 ZA ZA2012/09739A patent/ZA201209739B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL2578596T3 (pl) | 2017-09-29 |
| EP2578596A4 (en) | 2013-11-06 |
| CA2800019C (en) | 2015-05-26 |
| RU2593499C2 (ru) | 2016-08-10 |
| ES2633737T3 (es) | 2017-09-25 |
| KR101706519B1 (ko) | 2017-02-14 |
| BR112012029905B1 (pt) | 2022-01-11 |
| ZA201209739B (en) | 2014-03-26 |
| CN102247396A (zh) | 2011-11-23 |
| JP2013528167A (ja) | 2013-07-08 |
| DK2578596T3 (en) | 2017-07-17 |
| CA2800019A1 (en) | 2011-12-01 |
| KR20160019970A (ko) | 2016-02-22 |
| KR101625262B1 (ko) | 2016-05-27 |
| RU2012156419A (ru) | 2014-06-27 |
| EP2578596B1 (en) | 2017-04-19 |
| WO2011147316A1 (zh) | 2011-12-01 |
| JP5866737B2 (ja) | 2016-02-17 |
| CN102247396B (zh) | 2014-05-28 |
| EP2578596A1 (en) | 2013-04-10 |
| KR20130020906A (ko) | 2013-03-04 |
| MY164230A (en) | 2017-11-30 |
| MX346873B (es) | 2017-03-30 |
| BR112012029905A2 (pt) | 2019-08-06 |
| IN2012MN02623A (es) | 2015-06-12 |
| US9089586B2 (en) | 2015-07-28 |
| US20130150316A1 (en) | 2013-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012013469A (es) | Levocarrimicina, composiciones farmaceuticas, metodos de preparacion y usos de la misma. | |
| MX348653B (es) | Derivados ester de acido boronico ciclico y sus usos terapeuticos. | |
| EA201390409A1 (ru) | Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием | |
| EP4218723A3 (en) | Long-acting formulations of insulins | |
| BR112013005679A2 (pt) | imidazopiridazinas substituídas | |
| WO2008132229A3 (en) | Highly concentrated insulin solutions and compositions | |
| EA026385B9 (ru) | Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов | |
| MX2012007806A (es) | Composiciones farmaceuticas para administracion oral de peptidos de insulina. | |
| BR112012029395A2 (pt) | lactamas piperdinil-substituídas como moduladores de gpr119 | |
| NZ734152A (en) | Compounds, compositions and methods useful for cholesterol mobilisation | |
| TR200806298A2 (tr) | Farmasötik formülasyon | |
| CA2920410C (en) | Thienopiperidine derivative and use thereof | |
| MX2013002208A (es) | Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
| TR201009167A2 (tr) | Sefalosporin içeren farmasötik granüller. | |
| NZ630385A (en) | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance | |
| CA2805805C (en) | Bendamustine anionic-catioinic cyclopolysaccharide compositions | |
| AU2012207301A8 (en) | Apolipoprotein AIV as an antidiabetic peptide | |
| MX2012006265A (es) | Formulaciones disacaridas hipersulfatadas. | |
| MX2013013079A (es) | Composiciones que comprenden un agente antibacterial y tazobactam. | |
| WO2012151279A3 (en) | Induction of il-12 using immunotherapy | |
| MX2011006567A (es) | Formulaciones de fenilefrina con estabilidad mejorada. | |
| WO2011103586A3 (en) | Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine | |
| WO2011103524A3 (en) | Cyclic tetrapeptides and therapeutic applications thereof | |
| PT2313384E (pt) | Fenil-alquil-piperazinas tendo uma actividade moduladora do tnf | |
| TW200738703A (en) | 2-Carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |